For example, previous study described a 12-chemokine gene signature, and identified CCL19 as key chemokine for the maturation heterogeneity of tertiary lymphoid structures (TLS) in renal cell carcinoma, reflecting different TME immunological status and prognosis of cancers [10]. This evidence concerns the gene CCL19 and hereditary clear cell renal cell carcinoma.